Mechanisms of disease: New insights into the cellular and molecular pathology of Peyronie's disease

Nature Clinical Practice Urology

Volumn 2, Issue 6, 2005, Pages 291-297

  Gonzalez Cadavid, Nestor F ^a,b   Rajfer, Jacob ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Fibrosis; Inducible nitric oxide synthase; Myofibroblast; Penis; Stem cells

Indexed keywords

ALPHA TOCOPHEROL; AMINOBENZOIC ACID; BETA INTEGRIN; COLCHICINE; COLLAGENASE; CORTACTIN; CYCLIC GMP; CYTOKINE; DECORIN; FIBRIN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHODIESTERASE V INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; REACTIVE OXYGEN METABOLITE; RHO FACTOR; SILDENAFIL; TRANSFORMING GROWTH FACTOR BETA1; VERAPAMIL;

CELL DIFFERENTIATION; CYTOKINE RELEASE; DEFENSE MECHANISM; DISEASE MODEL; DRUG MECHANISM; ERECTILE DYSFUNCTION; FIBROBLAST; HUMAN; MALE; MYOFIBROBLAST; NONHUMAN; OSSIFICATION; OXIDATIVE STRESS; PAIN; PATHOPHYSIOLOGY; PENILE FIBROSIS; PENIS ERECTION; PENIS INJURY; PEYRONIE DISEASE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; REVIEW; STEM CELL; TUNICA ALBUGINEA; WOUND HEALING;

DISEASE PROGRESSION; HUMANS; MALE; PENILE INDURATION;

EID: 21344457266     PISSN: 17434270     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpuro0201     Document Type: Review

References (50)

1. Schwarzer U et al. (2001) The prevalence of Peyronie's disease: results of a large survey. BJU Int 88: 727-730
2. Mulhall JP et al. (2004) Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. J Urol 171 (Pt 1): 2350-2353
3. Usta MF et al. (2004) Relationship between the severity of penile curvature and the presence of comorbidities in men with Peyronie's disease. J Urol 171: 775-779
4. Carrieri MP et al. (1988) A case-control study on risk factors for Peyronie's disease. J Clin Epidemiol 51: 511-515
5. Usta MF et al. (2004) Stratification of penile vascular pathologies in patients with Peyronie's disease and in men with erectile dysfunction according to age: a comparative study. J Urol 172: 259-262
6. Levine LA (2003) Review of current nonsurgical management of Peyronie's disease. Int J Impot Res 15 (Suppl 5): S113-S120
7. Gonzalez-Cadavid NF and Rajfer J (2004) Molecular and cellular aspects of the pathophysiology of Peyronie's disease. Drug Discov Today 1: 99-104
8. El-Sakka AI et al. (1997) An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. J Urol 158: 2284-2290
9. El-Sakka AI et al. (1998) Histological and ultrastructural alterations in an animal model of Peyronie's disease. Br J Urol 81: 445-452
10. Intengan HD and Schiffrin EL (2001) Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 38: 581-587
11. Becker GJ et al. (2001) Pharmacological intervention in renal fibrosis and vascular sclerosis. J Nephrol 14: 332-339
12. Gholami SS et al. (2003) Peyronie's disease: a review. J Urol 169: 234-241
13. Gabbiani G (2003) The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200: 500-503
14. Li Y and Huard J (2002) Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol 161: 895-907
15. Mulhall JP (2003) Expanding the paradigm for plaque development in Peyronie's disease. Int J Impot Res 15 (Suppl 5): S93-S102
16. Gonzalez-Cadavid NF et al. (2002) Gene expression in Peyronie's disease. Int J Impot Res 14: 361-374
17. Devine CJ Jr et al. (1997) Proposal: trauma as the cause of the Peyronie's lesion. J Urol 157: 285-290
18. Gong R et al. (2003) Hepatocyte growth factor modulates matrix metalloproteinases and plasminogen activator/plasmin proteolytic pathways in progressive renal interstitial fibrosis. J Am Soc Nephrol 14: 3047-3060
19. Ehrlich HP (1997) Scar contracture: cellular and connective tissue aspects in Peyronie's disease. J Urol 57: 316-319
20. Davila HH et al. (2003) Fibrin as an inducer of fibrosis in the tunica albuginea of the rat: a new animal model of Peyronie's disease. BJU Int 91: 830-838
21. Somers KD and Dawson DM (1997) Fibrin deposition in Peyronie's disease plaque. J Urol 157: 311-315
22. Davila HH et al. (2004) Gene transfer of inducible nitric oxide synthase complementary DNA regresses the fibrotic plaque in an animal model of Peyronie's disease. Biol Reprod 71: 1568-1577
23. Davila H et al. (2005) Peyronie's disease is associated with an increase of plasminogen activator inhibitor-1 (PAI-1) at the RNA and protein levels. Urology 65: 645-648
24. Kim JJ et al. (2004) Novel animal model of Peyronie's disease by tunical injection of autologous blood. In Proceedings of the International Society for Sexual and Impotence Research Meeting: 2004 October 17-21; Buenos Aires, Argentina
25. Zargooshi J (2004) Trauma as the cause of Peyronie's disease: penile fracture as a model of trauma. J Urol 172: 186-188
26. Clarkson PM and Hubal MJ (2002) Exercise-induced muscle damage in humans. Am J Phys Med Rehabil 81 (Suppl): S52-S69
27. King JB (1998) Post-traumatic ectopic calcification in the muscles of athletes: a review. Br J Sports Med 32: 287-290
28. Bivalacqua TJ et al. (2002) Implications of nitric oxide synthase isoforms in the pathophysiology of Peyronie's disease. Int J Impot Res 14: 345-352
29. Sikka SC and Hellstrom WJ (2002) Role of oxidative stress and antioxidants in Peyronie's disease. Int J Impot Res 14: 353-360
30. Ferrini MG et al. (2002) Antifibrotic role of inducible nitric oxide synthase. Nitric Oxide 6: 283-294
31. Vernet D et al. (2002) Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model. Nitric Oxide 7: 262-276
32. Valente EG et al. (2003) PDE L-arginine and PDE inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures. Nitric Oxide 9: 229-244
33. El-Sakka AI et al. (1999) The effects of colchicine on a Peyronie's-like condition in an animal model. J Urol 161: 1980-1983
34. Quan TE et al. (2004) Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 36: 598-606
35. Gonzalez-Cadavid NF and Rajfer J (2004) Therapy of erectile function: potential future treatments. Endocrine 23: 167-176
36. Ferrini M et al. (2001) Aging-related expression of inducible nitric oxide synthase (iNOS) and markers of tissue damage in the rat penis. Biol Reprod 64: 974-982
37. Ferrini MG et al. (2004) Aging-related induction of inducible nitric oxide synthase (iNOS) is vasculoprotective in the arterial media. Cardiovascular Res 61: 796-805
38. Kovanecz I et al. (2005) Pioglitazone ameliorates penile corpora veno-occlusive dysfunction (CVOD) in a rat model of type 2 diabetes (abstract #1045]. In Proceedings of the 100th American Urological Association Annual Meeting: 2005 May 21-26; San Antonio, Texas
39. Qian A et al. (2004) Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture. Urology 64: 399-404
40. Tomasek JJ et al. (1999) Cellular structure and biology of Dupuytren's disease. Hand Clin 15: 21-34
41. O'Brien K et al. (2004) Analysis of the natural history of Peyronie's disease. In Proceedings of the International Society for Sexual and Impotence Research Meeting: 2004 October 17-21; Buenos Aires, Argentina
42. Vernet D et al. Evidence that osteogenic progenitor cells in the human tunica albuginea may originate from stem cells. Implications for Peyronie's disease. Biol Reprod, in press
43. Gelbard MK (1988) Dystrophic penile calcification in Peyronie's disease. J Urol 139: 738-740
44. Andresen R et al. (1996) Ultrasound and soft-tissue radiography to monitor local interferon-alpha 2B treatment in Peyronie's disease. Acta Radiol 37: 352-356
45. Hauck EW et al. (2003) Diagnostic value of magnetic resonance imaging in Peyronie's disease - a comparison both with palpation and ultrasound in the evaluation of plaque formation. Eur Urol 43: 293-299
46. Davis CJ Jr (1997) The microscopic pathology of Peyronie's disease. J Urol 157: 282-284
47. Mulhall JP et al. (2004) Chromosomal instability is demonstrated by fibroblasts derived from the tunica of men with Peyronie's disease. Int J Impot Res 16: 288-293
48. Mulhall JP et al. (2001) Perturbation of cell cycle regulators in Peyronie's disease. Int J Impot Res 13 (Suppl 5): S21 -S28
49. Mulhall JP et al. (2004) Peyronie's disease fibroblasts demonstrate tumorigenicity in the severe combined immunodeficient (SCID) mouse model. Int J Impot Res 16: 99-104
50. Schurch W (1999) The myofibroblast in neoplasia. Curr Top Pathol 93: 135-148